Evidence map›Paper›PMID 42253461›Full record

ArticleGlomerular diseases

Crescentic IgM-κ Monoclonal Immunoglobulin Deposition Disease with Thrombotic Microangiopathy in Waldenström's Macroglobulinemia: A Rare and Aggressive Monoclonal Gammopathy of Renal Significance Presentation - A Case Report and Literature Review.

Chalermchon Suttaluang, Pisut Katavetin, Jerasit Surintrspanont, Talerngsak Kanjanabuch

Abstract read
In one paragraph

Article in Glomerular diseases. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Chalermchon SuttaluangFaculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Pisut KatavetinFaculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Jerasit SurintrspanontDepartment of Pathology, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand.
Talerngsak KanjanabuchFaculty of Medicine, Chulalongkorn University, Bangkok, Thailand.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Monoclonal immunoglobulin deposition disease (MIDD) is a rare monoclonal gammopathy of renal significance (MGRS) characterized by linear, non-organized deposition of immunoglobulin fragments along glomerular, tubular, and vascular basement membranes. While light and heavy chain MIDDs are more frequently reported, IgM-associated MIDD is exceedingly rare, with only a few cases documented. Case Presentation: We report a 71-year-old man who presented with seronegative rapidly progressive glomerulonephritis (RPGN) and sub-nephrotic range proteinuria. Initial serologies were negative for autoimmune and infectious causes. A monoclonal workup revealed an IgM-κ paraprotein, prompting further evaluation. Kidney biopsy demonstrated diffuse crescentic glomerulonephritis (100%), linear IgM-κ deposits, and arterial thrombotic microangiopathy (TMA). Bone marrow studies confirmed lymphoplasmacytic lymphoma with an Conclusion: This case represents the first reported instance of IgM-κ MIDD presenting with both crescentic GN and TMA in the setting of WM, defining a uniquely aggressive dual-injury kidney phenotype. It highlights the diagnostic challenge of seronegative RPGN, in which MIDD should be included in the differential diagnosis. The case underscores the importance of integrated histopathology and hematologic genomics in identifying rare MGRS entities, recognizing that severe kidney injury may evolve rapidly despite appropriate management.

Indexed as

Crescentic glomerulonephritisIgM-κ paraproteinemiaMGASMIDDMonoclonal gammopathy of renal significanceMonoclonal immunoglobulin deposition diseaseMYD88 L265P mutationThrombotic microangiopathyWaldenström’s macroglobulinemia

Identifiers

PMID42253461
PMCPMC13241080

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.